Animal Drug Compounding Market Size, Share & Trends Analysis Report By Animal Type (Companion Animals, Livestock Animals), By Product (Anti-infective Agents, Anti-inflammatory Agents, Hormones & Substitutes, CNS Agents, GI Drugs), By Route of Administration, By Dosage Form, By Region, And Segment Forecasts, 2025-2034

Report Id: 1664 Pages: 180 Last Updated: 21 May 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of Animal Drug Compounding Market-

Animal Drug Compounding Market By Animal Type-

  • Companion Animals
    • Dogs
    • Cats
    • Others
  • Livestock Animals

Animal Drug Compounding Market

Animal Drug Compounding Market By Product-

  • Anti-infectives
    • Metranidazole
    • Ketaconazole
    • Others
  • Anti-inflammatory
    • Prednisolone
    • Tramadol
    • Others
  • CNS Agents
    • Potassium Bromide
    • Gabapentin
    • Other CNS Agents
  • GI Drugs
    • Apomorphine
    • Ursodiol
    • Cisapride
    • Other GI Drugs
  • Others
    • Methimazole
    • Others

Animal Drug Compounding Market By Route of Administration-

  • Oral
  • Injectable
  • Topical
  • Others

Animal Drug Compounding Market By Dosage Form-

  • Suspensions
  • Solutions
  • Capsules

Animal Drug Compounding Market By Region-

North America-

  • The US
  • Canada

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Animal Drug Compounding Market Snapshot

Chapter 4. Global Animal Drug Compounding Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Animal Type Estimates & Trend Analysis
5.1. by Animal Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Animal Type:

5.2.1. Companion Animals
5.2.1.1. Dogs
5.2.1.2. Cats
5.2.1.3. Others
5.2.2. Livestock Animals

Chapter 6. Market Segmentation 2: by Products Estimates & Trend Analysis
6.1. by Products & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Products:

6.2.1. Anti-infectives

6.2.1.1. Metranidazole
6.2.1.2. Ketaconazole
6.2.1.3. Others

6.2.2. Anti-inflammatory

6.2.2.1. Prednisolone
6.2.2.2. Tramadol
6.2.2.3. Others

6.2.3. CNS Agents

6.2.3.1. Potassium Bromide
6.2.3.2. Gabapentin
6.2.3.3. Other CNS Agents

6.2.4. GI Drugs

6.2.4.1. Apomorphine
6.2.4.2. Ursodiol
6.2.4.3. Cisapride
6.2.4.4. Other GI Drugs

6.2.5. Others

6.2.5.1. Methimazole
6.2.5.2. Others

Chapter 7. Market Segmentation 3: by Route of Administration Estimates & Trend Analysis
7.1. by Route of Administration & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Route of Administration:

7.2.1. Oral
7.2.2. Injectable
7.2.3. Topical
7.2.4. Others

Chapter 8. Market Segmentation 4: by Form Estimates & Trend Analysis
8.1. by Form & Market Share, 2024 & 2034
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Form:

8.2.1. Suspensions
8.2.2. Solutions
8.2.3. Capsules

Chapter 9. Animal Drug Compounding Market Segmentation 5: Regional Estimates & Trend Analysis

9.1. North America

9.1.1. North America Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
9.1.2. North America Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
9.1.3. North America Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021-2034
9.1.4. North America Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Form, 2021-2034
9.1.5. North America Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034

9.2. Europe

9.2.1. Europe Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
9.2.2. Europe Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
9.2.3. Europe Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021-2034
9.2.4. Europe Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Form, 2021-2034
9.2.5. Europe Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034

9.3. Asia Pacific

9.3.1. Asia Pacific Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
9.3.2. Asia Pacific Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
9.3.3. Asia-Pacific Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021-2034
9.3.4. Asia-Pacific Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Form, 2021-2034
9.3.5. Asia Pacific Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034

9.4. Latin America

9.4.1. Latin America Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
9.4.2. Latin America Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
9.4.3. Latin America Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021-2034
9.4.4. Latin America Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Form, 2021-2034
9.4.5. Latin America Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034

9.5. Middle East & Africa

9.5.1. Middle East & Africa Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
9.5.2. Middle East & Africa Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
9.5.3. Middle East & Africa Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021-2034
9.5.4. Middle East & Africa Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Form, 2021-2034
9.5.5. Middle East & Africa Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034

Chapter 10. Competitive Landscape

10.1. Major Mergers and Acquisitions/Strategic Alliances

10.2. Company Profiles


10.2.1. Akina Animal Health
10.2.2. Aurora Compounding
10.2.3. Caringbah Compounding Pharmacy
10.2.4. Central Compounding Center South
10.2.5. Chiron Compounding Pharmacy
10.2.6. Custom Med Compounding Pharmacy
10.2.7. Davis Islands Pharmacy and Compounding Lab
10.2.8. Dougherty's Pharmacy
10.2.9. Hoye's Pharmacy
10.2.10. Medisca Inc.
10.2.11. MEDS Canadian Compounding Pharmacy
10.2.12. Millers Pharmacy
10.2.13. Pace Pharmacy
10.2.14. People’s Choice Pharmacy
10.2.15. Pharmaca.
10.2.16. Pratt’s Compounding Pharmacy
10.2.17. Sixth Avenue Medical Pharmacy
10.2.18. Smith Caldwell Drug Store
10.2.19. Smith’s Pharmacy
10.2.20. Specialist Compounding Pharmacy Pte Ltd.
10.2.21. Tache Pharmacy
10.2.22. Triangle Compounding Pharmacy Inc.
10.2.23. Vertisis Custom Pharmacy
10.2.24. Victoria Compounding Pharmacy
10.2.25. Vimian
10.2.26. Wedgewood Pharmacy
10.2.27. Wellness Pharmacy of Cary
10.2.28. Other Prominent Players

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
4208
Security Code field cannot be blank!

Frequently Asked Questions

Animal Drug Compounding Market Size is valued at 2.36 billion in 2024 and is predicted to reach 5.15 billion by the year 2034

Animal Drug Compounding Market expected to grow at an 8.2% CAGR during the forecast period for 2025-2034

Wedgewood Pharmacy; Vimian; Pharmaca; Akina Animal Health; Triangle Compounding; Davis Islands Pharmacy and Compounding Lab

Animal Drug Compounding market is segmented based on animal type, product, route of administration, and dosage form.

North America region is leading the Animal Drug Compounding market.

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying